Esketamine on Postpartum Depression in Cesarean Section Women (EKET)

  • STATUS
    Recruiting
  • days left to enroll
    86
  • participants needed
    1248
  • sponsor
    Ailin Luo
Updated on 22 April 2022
depressed mood
cesarean section

Summary

This study was to explore the preventive effect of esketamine on postpartum depression in cesarean section, and to evaluate the safety of the drug

Description

Studies have shown that esketamine can treat clinical refractory depression, the drug takes effect quickly, can quickly eliminate the patient's suicide intention, low-dose maintenance treatment is conducive to the stability of the patient's condition, and less adverse reactions, is the current hot spot of antidepressant drug research. Esketamine has been approved by FDA for the treatment of refractory and suicidal depression, but can it effectively prevent and treat postpartum depression? It is not clear. Based on this, this study aims to explore the preventive effect of prophylactic administration of esketamine on postpartum depression in cesarean section, and evaluate the safety of the drug.

Details
Condition Esketamine, Postpartum Depression
Treatment Normal saline, Esketamine
Clinical Study IdentifierNCT04860661
SponsorAilin Luo
Last Modified on22 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Elective cesarean section
-40 years
Primipara
Singleton pregnancy
Sign informed consent

Exclusion Criteria

ASA grade III and above
Intracranial hypertension
Hypertension
Severe heart disease
Hyperthyroidism patients without treatment or insufficient treatment
Liver and kidney dysfunction
Preeclampsia or eclampsia
Mental disorder, mental retardation
Drug abuse and alcoholism
Contraindication of intraspinal anesthesia
The preoperative EPDS score ≥10
Participated in other clinical studies
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note